Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.32 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.46.3 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.4.6 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AY.75.2 (Delta)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
C.37 (Lambda)NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.9.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.6.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.34NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.12NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.9.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.4.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XAY.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.71NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBC.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DN.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CL.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.2.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.25NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.16NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CZ.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.1.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.29NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.4.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.47NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FK.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBC.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.26.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DS.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.5.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DV.6.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.2.14NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.4.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GM.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.20NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.26NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XAY.2.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CM.8.1.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.34NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.4.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.15.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.9.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FA.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
ER.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.4.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CQ.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used